Anne Forand

Paris, 75005, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Simtuzumab Attenuates Loxl2-Mediated Extracellular Matrix Remodeling and Preserves Cardiac Function in LMNA Mutation-Induced Dilated Cardiomyopathy.

Simtuzumab Attenuates Loxl2-Mediated Extracellular Matrix Remodeling and Preserves Cardiac Function in LMNA Mutation-Induced Dilated Cardiomyopathy.

Journal: Circulation. Heart failure

Published: March 17, 2026

Long-Term Dystrophin Replacement Therapy in Duchenne Muscular Dystrophy Causes Cardiac Inflammation.

Long-Term Dystrophin Replacement Therapy in Duchenne Muscular Dystrophy Causes Cardiac Inflammation.

Journal: JACC. Basic to translational science

Published: September 25, 2024

GDF5 as a rejuvenating treatment for age-related neuromuscular failure.

GDF5 as a rejuvenating treatment for age-related neuromuscular failure.

Journal: Brain : a journal of neurology

Published: November 22, 2023

Muscle regeneration affects Adeno Associated Virus 1 mediated transgene transcription.

Muscle regeneration affects Adeno Associated Virus 1 mediated transgene transcription.

Journal: Scientific reports

Published: January 19, 2022

NR1D1 controls skeletal muscle calcium homeostasis through myoregulin repression.

NR1D1 controls skeletal muscle calcium homeostasis through myoregulin repression.

Journal: JCI insight

Published: July 26, 2021

CD38-NADase is a new major contributor to Duchenne muscular dystrophic phenotype.

CD38-NADase is a new major contributor to Duchenne muscular dystrophic phenotype.

Journal: EMBO molecular medicine

Published: June 01, 2020

Combined Treatment with Peptide-Conjugated Phosphorodiamidate Morpholino Oligomer-PPMO and AAV-U7 Rescues the Severe DMD Phenotype in Mice.

Combined Treatment with Peptide-Conjugated Phosphorodiamidate Morpholino Oligomer-PPMO and AAV-U7 Rescues the Severe DMD Phenotype in Mice.

Journal: Molecular therapy. Methods & clinical development

Published: February 20, 2020

Novel function of PiT1/SLC20A1 in LPS-related inflammation and wound healing.

Novel function of PiT1/SLC20A1 in LPS-related inflammation and wound healing.

Journal: Scientific reports

Published: May 02, 2018

PiT1: from phosphate transport to insulin signaling

PiT1: from phosphate transport to insulin signaling

Journal: Medecine sciences : M/S

Published: June 15, 2017

Disruption of the Phosphate Transporter Pit1 in Hepatocytes Improves Glucose Metabolism and Insulin Signaling by Modulating the USP7/IRS1 Interaction.

Disruption of the Phosphate Transporter Pit1 in Hepatocytes Improves Glucose Metabolism and Insulin Signaling by Modulating the USP7/IRS1 Interaction.

Journal: Cell reports

Published: November 10, 2016

Disruption of the Phosphate Transporter Pit1 in Hepatocytes Improves Glucose Metabolism and Insulin Signaling by Modulating the USP7/IRS1 Interaction.

Disruption of the Phosphate Transporter Pit1 in Hepatocytes Improves Glucose Metabolism and Insulin Signaling by Modulating the USP7/IRS1 Interaction.

Journal: Cell reports

Published: February 03, 2016

Plasma fibroblast growth factor 23 concentration is increased and predicts mortality in patients on the liver-transplant waiting list.

Plasma fibroblast growth factor 23 concentration is increased and predicts mortality in patients on the liver-transplant waiting list.

Journal: PloS one

Published: February 27, 2013

Showing 1-12 of 13

Last Updated: 09/26/2026